Perrigo (PRGO) Depreciation & Amortization (CF) (2013 - 2026)

Perrigo's (PRGO) quarterly Depreciation & Amortization (CF) came in at $83.3 million in Q1 2026, up 4.26% year-on-year from $79.9 million in Q1 2025, and down 3.03% on a QoQ basis from $85.9 million in Q4 2025.

Perrigo (PRGO) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $83.3 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 4.26% year-over-year to $83.3 million in Q1 2026; TTM through Mar 2026 was $340.9 million, a 5.09% increase from a year earlier, with the FY2025 full-year figure at $337.5 million, up 3.56% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $83.3 million, down from $85.9 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PRGO reached as high as $97.1 million in Q4 2022 and fell as low as $69.5 million in Q2 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $85.0 million across 5 years, with a median of $85.4 million in 2025.
  • On a YoY basis, Depreciation & Amortization (CF) climbed as much as 32.29% in 2022 and fell as far as 23.12% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $97.1 million in 2022, then dropped by 11.53% to $85.9 million in 2023, then dropped by 6.52% to $80.3 million in 2024, then rose by 6.97% to $85.9 million in 2025, then slipped by 3.03% to $83.3 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $83.3 million in Q1 2026, $85.9 million in Q4 2025, and $85.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 83.30 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 83.30 Mn
Mar 28, 2026 83.30 Mn
Dec 31, 2025 85.90 Mn
Dec 31, 2025 85.90 Mn
Sep 27, 2025 85.40 Mn
Sep 27, 2025 85.40 Mn
Jun 28, 2025 86.30 Mn
Jun 28, 2025 86.30 Mn
Mar 29, 2025 79.90 Mn
Mar 29, 2025 79.90 Mn
Dec 31, 2024 80.30 Mn
Dec 31, 2024 80.30 Mn
Sep 28, 2024 82.30 Mn
Sep 28, 2024 82.30 Mn
Jun 29, 2024 81.90 Mn
Jun 29, 2024 81.90 Mn
Mar 30, 2024 81.40 Mn
Mar 30, 2024 81.40 Mn
Dec 31, 2023 85.90 Mn
Dec 31, 2023 85.90 Mn